
Bryan Y. Lee
Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | IWPI, 2445, 2615 |
| Total Applications | 446 |
| Issued Applications | 316 |
| Pending Applications | 28 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4675719
[patent_doc_number] => 20080213348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Agents for gene therapy of cerebrovascular disorders'
[patent_app_type] => utility
[patent_app_number] => 12/011341
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6930
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213348.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011341
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011341 | Agents for gene therapy of cerebrovascular disorders | Jan 23, 2008 | Abandoned |
Array
(
[id] => 4915615
[patent_doc_number] => 20080096215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 11/926833
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 62674
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11926833
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/926833 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR | Oct 28, 2007 | Abandoned |
Array
(
[id] => 4771442
[patent_doc_number] => 20080057100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Implantable device for delivery of therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/978047
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7474
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978047 | Implantable device for delivery of therapeutic agents | Oct 24, 2007 | Abandoned |
Array
(
[id] => 4745293
[patent_doc_number] => 20080089895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy'
[patent_app_type] => utility
[patent_app_number] => 11/906867
[patent_app_country] => US
[patent_app_date] => 2007-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9545
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11906867
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/906867 | Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy | Oct 3, 2007 | Abandoned |
Array
(
[id] => 23893
[patent_doc_number] => 07795234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene'
[patent_app_type] => utility
[patent_app_number] => 11/901989
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 20
[patent_no_of_words] => 6372
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901989 | Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene | Sep 19, 2007 | Issued |
Array
(
[id] => 4785485
[patent_doc_number] => 20080138814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Compositions and Methods for Modulation of KSR1 and KSR2 Interactions'
[patent_app_type] => utility
[patent_app_number] => 11/833029
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11318
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138814.pdf
[firstpage_image] =>[orig_patent_app_number] => 11833029
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/833029 | Compositions and methods for modulation of KSR1 and KSR2 interactions | Aug 1, 2007 | Issued |
Array
(
[id] => 4740563
[patent_doc_number] => 20080234216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'TGF-beta type receptor cDNAs encoded products and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/880894
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9711
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234216.pdf
[firstpage_image] =>[orig_patent_app_number] => 11880894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/880894 | TGF-beta type receptor cDNAs encoded products and uses therefor | Jul 23, 2007 | Abandoned |
Array
(
[id] => 4727999
[patent_doc_number] => 20080207543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/774954
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18874
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11774954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/774954 | MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY | Jul 8, 2007 | Abandoned |
Array
(
[id] => 4664095
[patent_doc_number] => 20080255002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Genetic manipulation method'
[patent_app_type] => utility
[patent_app_number] => 11/809578
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22003
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809578 | Genetic manipulation method | May 30, 2007 | Abandoned |
Array
(
[id] => 5027965
[patent_doc_number] => 20070269412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'PLURIPOTENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/755224
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10394
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269412.pdf
[firstpage_image] =>[orig_patent_app_number] => 11755224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/755224 | PLURIPOTENT CELLS | May 29, 2007 | Abandoned |
Array
(
[id] => 4976846
[patent_doc_number] => 20070218077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response'
[patent_app_type] => utility
[patent_app_number] => 11/749509
[patent_app_country] => US
[patent_app_date] => 2007-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23072
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218077.pdf
[firstpage_image] =>[orig_patent_app_number] => 11749509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/749509 | Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response | May 15, 2007 | Abandoned |
Array
(
[id] => 4839436
[patent_doc_number] => 20080279921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Gel-formulations of hydrophobic photosensitizers for mucosal applications'
[patent_app_type] => utility
[patent_app_number] => 11/800599
[patent_app_country] => US
[patent_app_date] => 2007-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2366
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279921.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800599 | Gel-formulations of hydrophobic photosensitizers for mucosal applications | May 6, 2007 | Abandoned |
Array
(
[id] => 4959744
[patent_doc_number] => 20080274169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Photosensitizer formulations for topical applications'
[patent_app_type] => utility
[patent_app_number] => 11/800147
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3171
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800147 | Photosensitizer formulations for topical applications | May 3, 2007 | Abandoned |
Array
(
[id] => 5091665
[patent_doc_number] => 20070231304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/668981
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 44909
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668981
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668981 | PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY | Jan 29, 2007 | Abandoned |
Array
(
[id] => 5259642
[patent_doc_number] => 20070213274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C)'
[patent_app_type] => utility
[patent_app_number] => 11/640897
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84858
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640897 | Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) | Dec 18, 2006 | Abandoned |
Array
(
[id] => 5070195
[patent_doc_number] => 20070191297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS'
[patent_app_type] => utility
[patent_app_number] => 11/565467
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26066
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191297.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565467
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565467 | METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5095073
[patent_doc_number] => 20070116682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/604909
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16798
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604909
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604909 | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof | Nov 27, 2006 | Abandoned |
Array
(
[id] => 5095075
[patent_doc_number] => 20070116684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/604918
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16792
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604918
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604918 | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof | Nov 27, 2006 | Abandoned |
Array
(
[id] => 4825815
[patent_doc_number] => 20080124802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Method for labeling specific cells within living cells or tissues'
[patent_app_type] => utility
[patent_app_number] => 11/598690
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5313
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11598690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/598690 | Method for labeling specific cells within living cells or tissues | Nov 13, 2006 | Abandoned |
Array
(
[id] => 4895622
[patent_doc_number] => 20080104722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/553125
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7867
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20080104722.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553125 | DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME | Oct 25, 2006 | Abandoned |